Full Press Release Details
| Contact: | Fresenius Medical Care AG & Co. KGaA | ||
| Oliver Maier | Else-Kr ner-Str.1 | ||
| Phone: | + 49 6172 609 2601 | 61352 Bad Homburg | |
| Fax: | + 49 6172 609 2301 | Germany | |
| www.fmc-ag.com | |||
| North America: | |||
| Terry L. Morris | |||
| Phone: | + 1 800 948 2538 | ||
| Fax: | + 1 615 345 5605 | ||
| E-mail: | ir@fmc-ag.com | February 27, 2012 |
Fresenius Medical Care Announces Upgraded
Corporate Credit Rating by Standard & Poor's
Bad Homburg, Germany
- Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's
largest provider of dialysis products and services, today announced that Standard & Poor's has upgraded the corporate
credit rating of Fresenius Medical Care AG & Co. KGaA to BB+' from BB'. In addition, the agency also
raised the ratings of Fresenius Medical Care's various unsecured senior notes to BB+' from BB'.
The agency affirmed the BBB- issue rating on Fresenius Medical Care's senior secured credit facilities. A stable
outlook has been assigned to all ratings.
About Fresenius Medical Care
Fresenius Medical Care is the world's largest
integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition
that affects more than 2.1 million individuals worldwide. Through its network of 2,898 dialysis clinics in North America, Europe,
Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 233,156 patients around the globe.
Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related
disposable products.
This release contains forward-looking statements
that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking
statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign
exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These
and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities
and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking
statements in this release.
Fresenius Medical Care AG & Co. KGaA, February 27, 2012